Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):247-256. doi: 10.1002/ccd.28753. Epub 2020 Jan 30.
OBJECTIVES: The aim was to assess long-term outcome after deferring intervention of coronary lesions with a fractional flow reserve (FFR) value of >0.80 in a real-world patient population and then to identify factors associated with deferred target lesion failure (DTLF). BACKGROUND: Deferring coronary interventions of intermediate lesions based on FFR measurement is safe, irrespective of the extent of coronary artery disease. However, FFR values near the cut-off of >0.80 may have less favorable outcome. METHODS: A retrospective analysis was performed in patients with deferred coronary intervention based on FFR value >0.80. The primary endpoint was DTLF, a composite of acute coronary syndrome (ACS) and any coronary revascularization, related to the initially deferred stenosis. RESULTS: A total of 600 patients, mean age of 66 ± 10 years, and 751 coronary lesions with negative FFR values (mean 0.88 ± 0.04) were included. The mean follow-up was 27 ± 15 months. DTLF occurred in 44 patients (7.3%), revascularization in 42 (7%), and ACS without revascularization in 2 patients (0.3%). Patients with DTLF more often had diabetes mellitus, previous coronary artery bypass grafting, multivessel disease (MVD), and lower FFR at inclusion. Multivariable regression analysis showed that lower deferred FFR values [FFR 0.81-0.85: hazard ratio (HR) 2.79 (95% CI [confidence interval]; 1.46-5.32), p .002], MVD [HR 1.98 (95% CI; 1.05-3.75), p .036], distal lesions [HR 2.43 (95% CI; 1.29-4.57), p .006], and lesions located in a saphenous vein graft (SVG) [HR 6.35 (95% CI; 1.81-22.28), p .004] were independent predictors for DTLF. CONCLUSIONS: The long-term rate of DTLF of initially deferred coronary lesions was 7.3%. Independent predictors for DTLF are lower deferred FFR value, the presence of MVD, distal lesions, and lesions in SVG.
目的:评估在真实患者人群中,对血流储备分数(FFR)值>0.80 的冠状动脉病变进行延迟干预后的长期结果,然后确定与延迟靶病变失败(DTLF)相关的因素。
背景:基于 FFR 测量对中间病变进行延迟介入是安全的,无论冠状动脉疾病的程度如何。然而,FFR 值接近>0.80 的临界点可能会有不太有利的结果。
方法:对基于 FFR 值>0.80 进行延迟冠状动脉介入的患者进行回顾性分析。主要终点是 DTLF,由最初延迟狭窄引起的急性冠脉综合征(ACS)和任何冠状动脉血运重建的复合事件。
结果:共纳入 600 例患者,平均年龄 66±10 岁,751 处 FFR 值为阴性(平均 0.88±0.04)的冠状动脉病变。平均随访时间为 27±15 个月。44 例(7.3%)患者发生 DTLF,42 例(7%)患者进行血运重建,2 例(0.3%)患者发生无血运重建的 ACS。发生 DTLF 的患者更常患有糖尿病、既往冠状动脉旁路移植术、多支血管疾病(MVD)和较低的 FFR 值。多变量回归分析显示,较低的延迟 FFR 值[FFR 0.81-0.85:风险比(HR)2.79(95%置信区间(CI);1.46-5.32),p=0.002]、MVD[HR 1.98(95% CI;1.05-3.75),p=0.036]、远端病变[HR 2.43(95% CI;1.29-4.57),p=0.006]和病变位于隐静脉桥(SVG)[HR 6.35(95% CI;1.81-22.28),p=0.004]是 DTLF 的独立预测因子。
结论:最初延迟的冠状动脉病变的长期 DTLF 发生率为 7.3%。DTLF 的独立预测因子是较低的延迟 FFR 值、存在 MVD、远端病变和 SVG 中的病变。
Catheter Cardiovasc Interv. 2021-2-1
J Am Coll Cardiol. 2016-9-13
Catheter Cardiovasc Interv. 2025-7
Eur J Clin Invest. 2025-7
Catheter Cardiovasc Interv. 2025-5
J Am Heart Assoc. 2024-11-5
Diagnostics (Basel). 2022-11-1
Catheter Cardiovasc Interv. 2019-5-29
Eur J Cardiothorac Surg. 2019-1-1
Am J Cardiol. 2018-6-9
Neth Heart J. 2018-8
Circ Cardiovasc Imaging. 2017-5
N Engl J Med. 2017-3-18